Drug ingredient firm Arseus says Q1 sales rise
BRUSSELS, April 9
BRUSSELS, April 9 (Reuters) - Belgo-Dutch medical firm Arseus said on Tuesday growth in its drug ingredients business offset declines in its dental business in the first quarter.
The world's biggest seller of drug ingredients to pharmacists said first-quarter sales rose by 1.7 percent to 133 million euros ($173.13 million).
However that was less than the 140.0 million euros forecast by Belgian brokerage KBC Securities. ($1 = 0.7682 euros) (Reporting By Ben Deighton, Editing By Ethan Bilby)
- Sierra Leone's chief Ebola doctor contracts the virus
- Exclusive: Ukraine rebel commander acknowledges fighters had BUK missile
- Gaza bloodshed deepens as airlines shun Israel |
- TransAsia Airways plane crashes in typhoon-hit Taiwan, killing 47 |
- South Korea ferry fugitive hid behind cabin wall, bags of cash at hand